Regulatory CMC Consulting for Pharmaceutical & Biotechnology Companies

From CMC Challenges to Regulatory Approval and Commercial Success.

Overcome regulatory challenges, reduce avoidable delays and keep your programme on track for its next critical milestone.

Polaris Regulatory combines deep CMC expertise with an independent, practical approach to resolve complex issues, bring the right people together and strengthen your path from development through approval and commercialisation.

Discuss Your CMC Challenge

Is Your Next CMC Milestone at Risk?

Even with experienced people and strong technical capabilities, problems can arise that threaten progress:

The consequences? Costly delays, unnecessary rework, increasing pressure and greater uncertainty around regulatory approval.

Better Decisions. Stronger Submissions. Greater Confidence in Approval Readiness.

Polaris helps you achieve what matters:

Fewer Avoidable Delays

Identify risks early and resolve issues before they threaten critical milestones.

Stronger Regulatory Submissions

Present clear, consistent and scientifically defensible evidence.

Faster, More Effective Decisions

Cut through complexity and get critical actions moving.

Better Coordination

Get departments, specialists and external partners working towards the same outcome.

Greater Regulatory Confidence

Anticipate questions, strengthen readiness and prepare for what comes next.

Commercial Readiness

Support the transition from development to approval, launch and ongoing growth.

How Polaris Helps You Get There

Operator at the control panel of stainless steel bioprocess vessels in a GMP manufacturing suite
01

Regulatory CMC Strategy & Advisory

Make informed decisions, anticipate regulatory requirements and address risks before they become costly obstacles.

 02

Regulatory Submissions & Approval Support

Prepare robust CMC submissions, communicate the scientific rationale clearly and respond effectively to health authority questions.

 03

CMC Programme Coordination

Bring departments, technical specialists and external partners together, resolve conflicting priorities and get critical work completed.

 04

Independent Senior CMC Expertise

Access experienced regulatory judgement, an objective perspective and practical support during critical programme stages.

 05

Commercial Readiness & Lifecycle Support

Prepare for commercialisation, manufacturing changes, regulatory commitments and expansion into new markets.
Explore Our CMC Services

Why Polaris? Because Expertise Alone Isn't Always Enough.

Deep technical knowledge. Clear thinking. Practical action.
Polaris brings a different approach to complex regulatory challenges.

Three scientists in a laboratory reviewing results together on a clipboard and tablet

We simplify complexity. Making difficult scientific and regulatory issues easier to understand and act upon.

We bring people together. Connecting the right expertise across departments and external partners.

We get things done. Turning discussions and decisions into clear, practical action.

We make submissions easier to assess. Presenting the science, evidence and regulatory rationale clearly for reviewers.

We stay calm under pressure. Providing considered judgement and practical solutions when the stakes are high.

Our focus is simple: helping you achieve your next critical milestone without unnecessary complexity, cost or delay.

From Early Development to Approval and Beyond

Development

Get the Foundations Right

Establish regulatory strategies, identify risks and prepare for the next development milestone.

Submission & Approval

Strengthen Your Case

Bring the evidence, people and regulatory documentation together for a strong, coherent submission.

Commercial Growth

Prepare for What's Next

Support commercial readiness, post-approval changes, market expansion and product growth.

Explore the CMC Development Journey

Experience gained across

Insights

Practical perspectives on Regulatory CMC.

Articles drawn from real experience across drug development, regulatory submissions and CMC strategy, written for people working in the field.

Analytical CMC

Discriminatory Power: The Make or Break Factor in Dissolution Methods

Dissolution testing is one of the most widely used tools in drug product development but not all methods are created equal. Why discriminatory power is the critical factor that determines whether your method is truly fit for purpose.

Read on LinkedIn ↗
Biologics · CMC

Where Should Bioburden Filtration Occur in a mAb Purification Train?

Placement of bioburden reduction filtration in a monoclonal antibody purification process is a decision with significant downstream implications. How to examine the key considerations and make the right call.

Read on LinkedIn ↗
Regulatory Strategy

Why Clarity Is the Most Underrated CMC Skill

Technical expertise matters. But the ability to communicate complex CMC information clearly to reviewers, to teams, to senior stakeholders is what separates good regulatory work from great regulatory work.

Read on LinkedIn ↗
Leadership · Industry

The Future of Regulatory Leadership in Biopharma

The role of the regulatory leader is changing. As pipelines grow more complex and global, what does effective regulatory leadership look like and what will it demand of the next generation?

Read on LinkedIn ↗
Biotech · Operations

Scaling Teams in Biotech Lessons Learned

Growing a regulatory or CMC function inside a fast-moving biotech is one of the most underestimated challenges in drug development. Practical lessons from the inside on what works, what doesn't, and what to do differently.

Read on LinkedIn ↗
Leadership · Decision-Making

The Decisions We Make Under Pressure

When timelines are tight and the stakes are high, the quality of our decisions often determines the outcome. An honest look at how pressure shapes the choices we make in drug development and what we can do about it.

Read on LinkedIn ↗
CMC Strategy · Launch

CMC Agility: The New Determinant of Launch Readiness

Technical readiness alone is no longer enough. The ability to adapt CMC strategy quickly in response to health authority feedback, manufacturing realities and shifting timelines is now one of the defining factors in whether a product reaches the market on time.

Read on LinkedIn ↗

Straight Answers.
Sound Judgement.
A Commitment to Results.

We believe effective Regulatory CMC support should make difficult challenges easier, not more complicated.

Our approach is built on scientific rigour, honesty, collaboration, clear communication and practical solutions.

We respect the expertise of your people, challenge assumptions when necessary and focus on what genuinely needs to be done.

We don't simply advise on what needs to happen. We help make it happen.

Meet Daniel Kavanagh

Founder & Managing Director, Polaris Regulatory

Daniel brings extensive Regulatory CMC experience across global pharmaceutical, biotechnology and consulting environments.

He combines technical expertise with an ability to see the bigger picture, bring people together and make complex decisions easier.

His independent, calm and practical approach helps organisations overcome obstacles and maintain progress when the pressure is on.

Meet Daniel dkavanagh@polarisregulatory.com
Daniel Kavanagh

Don't Let CMC Challenges Delay Your Next Milestone.

Whether you're preparing a regulatory submission, facing development challenges or moving towards commercialisation, Polaris can help you identify what needs to happen and get the right work done.

Discuss Your CMC Challenge